Journal of Clinical Chemistry and Laboratory Medicine
Open Access

Note on Potency of Placebo Effect

Monica Peter^{* *}Correspondence: Monica Peter, Department of Health Sciences and Technology, Harvard Medical School, Boston, MA, USA, Email:

Author info »

About the Study

Any remedy that contains no active ingredients, such as a sugar pill, is referred to be a placebo. Many clinical trials have shown that people who took the placebo instead of the active medication had a reduction in symptoms. Belief in a treatment may be enough to modify a person's physical illness's direction. When a person's physical or mental health appears to improve after receiving a placebo treatment, this is known as the placebo effect. The word "placebo" comes from Latin and means "I shall please." It refers to a treatment that looks to be genuine but is intended to have no therapeutic benefit. A sugar pill, water or salt water (saline) injection, or even a fictitious surgical procedure can all be used as placebos. Placebos are frequently employed in clinical trials to assist researcher’s better grasp the true impact of a new medication both the good and negative impacts.

"The placebo-controlled trial is commonly considered as the gold standard for evaluating the efficacy of new treatments," according to the researchers. The qualities of the placebo, if the pill seems to be genuine, the person ingesting it is more likely to assume it contains active treatment. A scientist compares the results of an experimental treatment for a disease with those acquired from a placebo to prove a novel treatment effective above and beyond the psychological results of a simple belief in the drug's power to cure. According to studies, larger tablets indicate a higher dose than smaller pills, and eating two pills appears to be more effective than swallowing one. Injections, on average, have a stronger placebo effect than tablets. Placebos have long been employed in clinical studies and are an important component of new treatment research. Patients in clinical trials are informed that they may be given a treatment for ethical (moral) grounds. In most cases, one group of patients receives the drug while the other (the 'control group') receives a placebo. It's possible that the placebo is a sugar pill. In certain circumstances, neither the subjects nor the researchers are aware of whether they are taking the active or inert (placebo) chemical. The mind body connection has been the focus of placebo effect research. Placebo-controlled studies are justified provided they are based on good methodological considerations and do not put research participants at an undue risk of harm. The placebo effect is said to be caused by a person's expectations, according to one popular theory. The randomized trial was a key methodological innovation in medicine, and controlled placebo-controlled (RCT) double-blind studies offered the best evidence for novel treatments. Even the researchers aren't always aware of what's going on (this is called a double-blind test). When the data from both groups are compared, the medication's effects should be visible. It could be in the form of a pill, a shot, or another "false" treatment. The only feature that all placebos have in common is that they do not really contain any active substances that can affect the health. During investigation, researchers have employed placebos to see what effect a new drug or other treatment might have on a certain condition. When the relevant treatment is known to reduce mortality or morbidity, this strategy is highly useful. They're used to see if a new health-care treatment, such as a medicine, appears to be beneficial or not. This was promoted by Henry Beecher's famous proto-meta analysis, which stated that roughly 35% of patients responded effectively to placebo treatment. If a person expects a pill to do anything, it's possible that the body's own chemistry can produce results that are comparable to those of a drug. In an 'add-on' method, the active and placebo therapies can be compared by keeping the participants on the same maintenance medications and then adding the active therapy to one arm and the placebo to the other. One drawback of the placebo effect is that it can be difficult to tell the difference between it and the real effects of a medicine during a study. Finding strategies to differentiate between the placebo effect and the main effects could enhance treatment and reduce drug testing costs. More research could also lead to new ways to employ the placebo effect to cure disease. Patients in the placebo control arms seemed to improve sometimes dramatically. Some believe that using placebos is generally unethical because other study designs would yield comparable results while posing less harm to individual research participants. The placebo is a pharmacologically inactive drug (usually a sugar pill) that serves as the clinical researcher's control trial. Rather of the qualities of the placebo, the placebo effect is caused by the person's belief in the treatment's value and their expectation of feeling better. Medications known as "pure placebos" have an active effect on the body but not on the ailment being treated. Others say that using placebos is necessary to protect society from the dangers that could arise from widespread use of inadequate medical therapies. In current history, the use of a placebo in clinical research has aroused criticism in the medical community. A placebo is a medical treatment that does not appears to be "real" yet.